Form D · Biotechnology
Vascular Perfusion Solutions, Inc.
San Antonio, TX · CIK 0001779735
Offering snapshot reported May 30, 2025 · SEC filing
- Reported sold
- $147M Offering amount: $344M
- Investors reported
- 21 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- May 16, 2025 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| May 30, 2025 | Initial | $147,017,491 | No comparison | 21 | SEC filing |
| Jun 8, 2023 | Initial | $500,000 | No comparison | 1 | SEC filing |
| May 20, 2022 | Initial | $500,000 | No comparison | 1 | SEC filing |
| Nov 12, 2021 | Initial | $850,000 | No comparison | 2 | SEC filing |
| Aug 2, 2021 | Initial | $1,050,000 | No comparison | Not reported | SEC filing |
| Aug 26, 2020 | Initial | $2,375,000 | No comparison | 6 | SEC filing |
| Oct 22, 2019 | Initial | $602,402 | No comparison | 13 | SEC filing |
| Jun 24, 2019 | Initial | $2,000,000 | No comparison | 1 | SEC filing |
Offering details
- Securities
- Equity, Option to acquire, Security to be acquired
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-547713
Includes $4,378,939 value of securities converted in the offering.
Source: Form D, filed May 30, 2025. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Kristina Andrijauskaite | Executive |
| Leon Bunegin | Director, Executive |
| Tom De Brooke | Director, Executive |
| Toni Haenninen | Executive |
| Celia Jairala | Director |
| C. Thomas Mayes | Director, Executive |
| Mark Muller | Director |
| Paul Perry | Executive |
| Rafael Veraza | Director, Executive |
| Klaus Weiswurm | Director |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
8647 Wurzbach Road, Suite J 200
San Antonio, TX, 78240
San Antonio, TX, 78240